Evidence map›Paper›PMID 41240177›Full record

ArticleInternational ophthalmology2025

Subbrow blepharoplasty for mild and moderate brow ptosis in Caucasians.

Titap Yazıcıoğlu, Anıl Ağaçkesen, Ömer Faruk Boğazlıyan

Abstract read
PubMed Publisher
In one paragraph

Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Titap YazıcıoğluKartal Dr.Lütfi Kırdar City Hospital, Ophthalmology Clinic, Istanbul, Turkey.
Anıl AğaçkesenKartal Dr.Lütfi Kırdar City Hospital, Ophthalmology Clinic, Istanbul, Turkey. anilagackesen@gmail.com.ORCID http://orcid.org/0000-0003-4694-4683
Ömer Faruk BoğazlıyanKartal Dr.Lütfi Kırdar City Hospital, Ophthalmology Clinic, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study evaluates the effectiveness and clinical outcomes of subbrow blepharoplasty for treating upper eyelid skin fold due to mainly brow ptosis and lateral hooding in Caucasian patients with mild to moderate brow ptosis.

methodsBetween 2023 and 2024, 33 patients (25 female and 8 male, aged 47 to 71) underwent subbrow skin excision to address functional and cosmetic concerns. Six months post-procedure, we assessed patient satisfaction using a Likert-type scale and documented complications, scar visibility, and nerve-related symptoms to evaluate the procedure's outcomes.

resultsFeedback from patients revealed a high level of satisfaction with both functional and aesthetic results. Cases that emphasized functionality showed significant improvements in visual field metrics. Early complications following surgery were minimal, primarily limited to temporary redness and swelling. By the six-month follow-up, evident scarring was rare, and there were no reported cases of sensory deficits, lagophthalmos, or significant brow descent. Evaluations using a Likert scale indicated high satisfaction levels, with 25 patients (75.7%) reporting significant or considerable improvement.

conclusionsSubbrow blepharoplasty is an effective, minimally invasive procedure for addressing brow ptosis and lateral hooding in Caucasian patients. It boasts high satisfaction rates, minimal complications, and rarely results in visible scarring. These positive outcomes demonstrate its value as a preferred surgical option for patients seeking both functional and cosmetic improvements.

Indexed as

BlepharoplastyBlepharoptosisEyebrowsEyelidsWhite PeopleAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedPatient SatisfactionRetrospective StudiesTreatment OutcomeBlepharoplastyBrow ptosisCaucasiansLateral hoodingSubbrow excision

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.